Case study : Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome

Abstract Neuroleptic-induced catatonia is reported in an adolescent patient who responded successfully to lorazepam. The authors propose five discrete stages toward the progression of neuroleptic malignant syndrome, each with a separate treatment.

[1]  G. Addonizio The Pharmacologic Basis of Neuroleptic Malignant Syndrome , 1991 .

[2]  J. Davis,et al.  Pharmacotherapy of Neuroleptic Malignant Syndrome , 1991 .

[3]  A. Lazarus,et al.  Neuroleptic Malignant Syndrome: Diagnostic Issues , 1991 .

[4]  P. Keck,et al.  Epidemiology of Neuroleptic Malignant Syndrome , 1991 .

[5]  J. Coyle,et al.  Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder. , 1991, Pediatrics.

[6]  A. Nierenberg,et al.  Risk factors for neuroleptic malignant syndrome. A case-control study. , 1989, Archives of general psychiatry.

[7]  P. Rosebush,et al.  A prospective analysis of 24 episodes of neuroleptic malignant syndrome. , 1989, The American journal of psychiatry.

[8]  V. Patrick,et al.  Delirium with dystonia: a variant of neuroleptic malignant syndrome? , 1989, The American journal of psychiatry.

[9]  W. Walker Spectrum Concept of Neuroleptic Malignant Syndrome , 1988, British Journal of Psychiatry.

[10]  G. Christodoulou,et al.  Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam , 1988, Acta psychiatrica Scandinavica.

[11]  S. Caroff,et al.  Neuroleptic malignant syndrome , 1980, Psychopharmacology bulletin.

[12]  C. Sullivan A Possible Variant of the Neuroleptic Malignant Syndrome , 1987, British Journal of Psychiatry.

[13]  S. Roth,et al.  Neuroleptic malignant syndrome: review and analysis of 115 cases , 1987, Biological Psychiatry.

[14]  T. Beresford,et al.  Lorazepam for psychogenic catatonia. , 1987, The American journal of psychiatry.

[15]  J. Levenson Neuroleptic malignant syndrome. , 2007, The American journal of psychiatry.

[16]  M. Amore,et al.  Pridinolum mesylate and neuroleptic malignant syndrome. , 1985, The American journal of psychiatry.

[17]  G. Fricchione Neuroleptic catatonia and its relationship to psychogenic catatonia , 1985, Biological Psychiatry.

[18]  A. Stoudemire,et al.  Neuroleptic Malignant Syndrome and Neuroleptic-Induced Catatonia: Differential Diagnosis and Treatment , 1985, International journal of psychiatry in medicine.

[19]  G. Fricchione,et al.  Intravenous Lorazepam in Neuroleptic‐Indueed Catatonia , 1983, Journal of clinical psychopharmacology.

[20]  G. F. Anderson,et al.  ECT in the neuroleptic malignant syndrome: case report. , 1983, The Journal of clinical psychiatry.

[21]  Kaushik Sk,et al.  Malignant neuroleptic syndrome due to haloperidol. (A case report). , 1983 .

[22]  Kenneth Mark Colby,et al.  Signs and Symptoms , 1981 .

[23]  B. Pethö,et al.  Reversal of Neuroleptic-Induced Stupor by Procyclidin , 1979 .

[24]  B. Pethö,et al.  Reversal of neuroleptic-induced stupor by procyclidin. Two case reports and their theoretical implications. , 1979, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

[25]  A. Gelenberg,et al.  Catatonic reactions to high-potency neuroleptic drugs. , 1977, Archives of general psychiatry.

[26]  W. Brannon,et al.  Phenothiazine reaction simulating acute catatonia. , 1976, Postgraduate medicine.

[27]  A. Gelenberg THE CATATONIC SYNDROME , 1976, The Lancet.

[28]  R. Waziri,et al.  Hyperpyrexia in catatonic states. , 1976, Diseases of the nervous system.